Danger of Antacid Medications
by
Dr. David Brownstein
Recently
by Dr. David Brownstein: A
New Illness Strikes: Media-Iodophobia
The U.S. Food
and Drug Administration (FDA) announced a safety alert for proton
pump inhibitors (PPIs). PPIs are a class of medications commonly
used to treat stomach and duodenal ulcers, reflux esophagitis, and
other gastric problems. PPIs include:
AcipHex
(rabeprazole sodium)
Dexilant (dexlansoprazole)
Nexium (esomeprazole magnesium)
Omeprazole (omeprazole) Over-the-Counter (OTC)
Prevacid (lansoprazole) and OTC Prevacid 24hr
Prilosec (omeprazole) and OTC
Protonix (pantoprazole sodium)
Vimovo (esomeprazole magnesium and naproxen)
Zegerid (omeprazole and Sodium bicarbonate) and OTC
The FDA stated,
the use of stomach acid drugs known as proton pump inhibitors
(PPIs) may be associated with an increased risk of Clostridium difficileassociated
diarrhea (CDAD). A diagnosis of CDAD should be considered for patients
taking PPIs who develop diarrhea that does not improve.(1)
C. difficile
is a bacterium that can infect the colon and cause severe, life-threatening
diarrhea. It causes over three million cases of diarrhea per year
in the U.S. Approximately 1-4% of patients with C. difficile die
from the illness.
Those who read
my books don't have to wait years for the FDA to act. Three years
ago in Drugs That Dont Work and Natural Therapies That Do,
I wrote about the consequences of long-term use of PPIs. I stated,
The reason we are seeing such a dramatic increase in C. difficile
infections is clear; it is due to the overuse of powerful antacid
medications.
Read
the rest of the article
February
10, 2012
David
Brownstein, M.D. is a Board-Certified family physician and is one
of the foremost practitioners of holistic medicine. He is the Medical
Director of the Center for Holistic Medicine in West Bloomfield,
MI. Dr. Brownstein has lectured internationally to physicians and
others about his success in using natural hormones and nutritional
therapies in his practice.
Copyright
© 2012 Dr. David Brownstein
|